Elevation Oncology, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Elevation Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Elevation Oncology, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 59.1M shares, a 26.2% increase year-over-year.
  • Elevation Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 34.1M shares, a 46.5% increase from 2022.
  • Elevation Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 23.3M shares, a 91.8% increase from 2021.
  • Elevation Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 12.1M shares, a 1432% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 59.1M +12.3M +26.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 59M +30.6M +108% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 47.4M +23.8M +101% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 34.1M +10.8M +46.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 46.8M +23.6M +101% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 28.4M +5.15M +22.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 23.6M +402K +1.73% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 23.3M +11.1M +91.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 23.3M +176K +0.76% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 23.3M +22.2M +2123% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 23.2M +22.4M +2800% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 12.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 23.1M +22.3M +2816% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 1.05M +257K +32.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 801K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 793K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 789K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.